In addition, by stereotaxic infusion of AAV-P301L-hTau, we could only achieve 2.5-times increase of tau proteins in the hippocampal CA3 region, which was closer to the observed increased level in the AD brains, and much lower than that (~13-fold) in Tg4510 transgenic mice. This evidence concerns the gene MAPT and Alzheimer disease.